Co-Diagnostics, Inc.

CODX

$0.3164

Name : Co-Diagnostics, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $19,266,414.00

EPSttm : -1.15

Co-Diagnostics, Inc.

$0.3164

4.50%

$0.0149

Float Short %

4.33

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

EPS Last/This Y

0.45

EPS This/Next Y

0.4

Price

0.32

Target Price

Analyst Recom

Performance Q

8.99

Relative Volume

0.04

Beta

1.2

Ticker: CODX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	CODX	0.3458	0.03	0.00	4158
2025-10-21	CODX	0.3383	0.02	0.02	4714
2025-10-22	CODX	0.3205	0.02	0.12	4768
2025-10-23	CODX	0.3306	0.03	0.63	4837
2025-10-24	CODX	0.3508	0.06	0.50	5252
2025-10-27	CODX	1.19	0.06	0.43	4836
2025-10-28	CODX	0.57	0.67	0.64	29594
2025-10-29	CODX	0.4933	0.52	0.37	36509
2025-10-30	CODX	0.4564	0.39	0.36	44042
2025-10-31	CODX	0.4626	0.39	0.58	41977
2025-11-03	CODX	0.402	0.40	0.28	26286
2025-11-04	CODX	0.3815	0.43	1.32	27026
2025-11-05	CODX	0.3916	0.47	0.73	28991
2025-11-06	CODX	0.3958	0.49	0.44	31961
2025-11-07	CODX	0.4099	0.47	0.49	32158
2025-11-10	CODX	0.3901	0.55	0.44	21998
2025-11-11	CODX	0.393	0.51	0.31	21657
2025-11-12	CODX	0.3886	0.50	0.23	21845
2025-11-13	CODX	0.3771	0.46	0.65	23391
2025-11-14	CODX	0.3364	0.46	0.98	23722
2025-11-17	CODX	0.3182	0.26	0.37	17504
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	CODX	0.35	46.5	-	-0.72
2025-10-21	CODX	0.34	46.5	-	-0.72
2025-10-22	CODX	0.32	46.5	-	-0.72
2025-10-23	CODX	0.33	46.5	-	-0.72
2025-10-24	CODX	0.35	46.5	-	-0.72
2025-10-27	CODX	1.25	46.5	-	-0.72
2025-10-28	CODX	0.57	46.5	-	-0.72
2025-10-29	CODX	0.49	46.5	-	-0.72
2025-10-30	CODX	0.47	46.5	-	-0.72
2025-10-31	CODX	0.46	46.5	-	-0.72
2025-11-03	CODX	0.40	42.0	-	-0.68
2025-11-04	CODX	0.38	42.0	-	-0.68
2025-11-05	CODX	0.39	42.0	-	-0.68
2025-11-06	CODX	0.39	42.0	-	-0.68
2025-11-07	CODX	0.41	51.1	-	-0.68
2025-11-10	CODX	0.39	51.1	-	-0.68
2025-11-11	CODX	0.39	51.1	-	-0.68
2025-11-12	CODX	0.39	51.1	-	-0.68
2025-11-13	CODX	0.37	51.1	-	-0.68
2025-11-14	CODX	0.34	42.0	-	-0.79
2025-11-17	CODX	0.32	42.0	-	-0.79
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	CODX	0.00	4.40	1.02
2025-10-21	CODX	0.00	4.40	1.02
2025-10-22	CODX	0.00	4.40	1.02
2025-10-23	CODX	0.00	4.40	1.02
2025-10-24	CODX	0.00	4.40	1.02
2025-10-27	CODX	0.00	4.86	0.26
2025-10-28	CODX	0.00	4.86	0.26
2025-10-29	CODX	0.00	4.86	0.26
2025-10-30	CODX	0.00	4.86	0.26
2025-10-31	CODX	0.00	4.86	0.26
2025-11-03	CODX	0.00	3.49	0.21
2025-11-04	CODX	0.00	3.49	0.21
2025-11-05	CODX	0.00	3.49	0.21
2025-11-06	CODX	0.00	3.49	0.21
2025-11-07	CODX	0.00	3.49	0.21
2025-11-10	CODX	0.00	2.78	0.21
2025-11-11	CODX	0.00	2.78	0.21
2025-11-12	CODX	0.00	2.78	4.49
2025-11-13	CODX	0.00	2.78	4.49
2025-11-14	CODX	0.00	2.78	4.38
2025-11-17	CODX	0.00	4.58	4.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

Institutional Transactions

4.58

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-98.8

Target Price

P/E

Forward P/E

PEG

P/S

37.77

P/B

0.38

P/Free Cash Flow

EPS

-0.96

Average EPS Est. Cur. Y

-0.79

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6336.27

Relative Volume

0.04

Return on Equity vs Sector %

-114.4

Return on Equity vs Industry %

-105.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

Co-Diagnostics, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 132

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today

news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance

stock history CODX – Co-Diagnostics, Inc. invest stock market

stock prices CODX premarket after hours

ticker CODX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CODX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y